RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients

NCT07056478 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Sarcopenia in Elderly

Interventions

DRUG: Denosumab (Prolia)
DRUG: Zoledronic acide (Aclasta)

Sponsor

Prince of Wales Hospital, Shatin, Hong Kong